Hematology NewsFeds advance cancer moonshot with expert panel, outline of goalsApril 5, 2016CMLCLLIndolent LymphomaMultiple MyelomaBreast CancerGenitourinary CancerGynecologic Cancer
Oncology PracticePSA screens could be cost effective if low-risk cases went untreatedApril 4, 2016Genitourinary Cancer
Oncology PracticeHypofractionated radiation regimen noninferior for low-risk prostate cancerApril 4, 2016Genitourinary Cancer
Oncology PracticeLarge cohort study confirms link between pioglitazone, bladder cancerMarch 30, 2016Genitourinary CancerPreventive Care
Oncology PracticeASCO endorses EAU guidelines on advanced bladder cancerMarch 21, 2016Genitourinary Cancer
Oncology PracticeTrial supports combined androgen suppression, radiotherapy for prostate cancerMarch 14, 2016Genitourinary Cancer
Oncology PracticeMets to liver linked with lowest survival in men with CRPCMarch 7, 2016Genitourinary Cancer
Oncology PracticeRadiotherapy for prostate cancer linked to higher risk of secondary malignanciesMarch 2, 2016Genitourinary CancerPatient & Survivor Care
Oncology PracticeLow serum vitamin D may signal more aggressive prostate cancerFebruary 22, 2016Genitourinary Cancer
The Journal of Community and Supportive OncologyA novel treatment approach prolonging survival in an uncommon metastatic primary bladder adenocarcinomaFebruary 21, 2016Genitourinary Cancer
Oncology PracticeDiet, lifestyle factors add up in reducing risk of prostate cancer deathFebruary 19, 2016Genitourinary Cancer
Oncology PracticeBipolar androgen therapy may be new option for hormone-sensitive prostate cancerFebruary 12, 2016Genitourinary Cancer
Oncology PracticeStatins don’t appear to compromise effectiveness of abirateroneFebruary 12, 2016Genitourinary Cancer
